These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34331977)

  • 1. Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics.
    Lombardo F; Salzano G; Bombaci B; Basile P; Lucania G; Alibrandi A; Passanisi S
    Diabetes Res Clin Pract; 2021 Aug; 178():108988. PubMed ID: 34331977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.
    Di Dalmazi G; Maltoni G; Bongiorno C; Tucci L; Di Natale V; Moscatiello S; Laffi G; Pession A; Zucchini S; Pagotto U
    BMJ Open Diabetes Res Care; 2020 Oct; 8(2):. PubMed ID: 33115820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Control Improvement in Italian Children and Adolescents With Type 1 Diabetes Followed Through Telemedicine During Lockdown Due to the COVID-19 Pandemic.
    Predieri B; Leo F; Candia F; Lucaccioni L; Madeo SF; Pugliese M; Vivaccia V; Bruzzi P; Iughetti L
    Front Endocrinol (Lausanne); 2020; 11():595735. PubMed ID: 33424771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of COVID lockdown on glycaemic control in paediatric patients with type 1 diabetes: A systematic review and meta-analysis of 22 observational studies.
    Han Y; Chen Y; Sun C; Zhou Z
    Front Endocrinol (Lausanne); 2022; 13():1069559. PubMed ID: 36531473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic control in people with type 1 diabetes using a hybrid closed loop system and followed by telemedicine during the COVID-19 pandemic in Italy.
    Longo M; Caruso P; Petrizzo M; Castaldo F; Sarnataro A; Gicchino M; Bellastella G; Esposito K; Maiorino MI
    Diabetes Res Clin Pract; 2020 Nov; 169():108440. PubMed ID: 32926958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit - what have we learned from the COVID-19 lockdown?
    Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Levran N; Chorna E; Dekel M; Barash G; Landau Z; Pinhas-Hamiel O
    Acta Diabetol; 2021 Jun; 58(6):697-705. PubMed ID: 33511493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
    Hakonen E; Varimo T; Tuomaala AK; Miettinen PJ; Pulkkinen MA
    BMC Pediatr; 2022 Jan; 22(1):48. PubMed ID: 35045807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
    Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
    Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teleassistance for Patients With Type 1 Diabetes During the COVID-19 Pandemic: Results of a Pilot Study.
    Parise M; Tartaglione L; Cutruzzolà A; Maiorino MI; Esposito K; Pitocco D; Gnasso A; Irace C
    J Med Internet Res; 2021 Apr; 23(4):e24552. PubMed ID: 33769945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Youth with Type 1 Diabetes Had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 Pandemic.
    Abdulhussein FS; Chesser H; Boscardin WJ; Gitelman SE; Wong JC
    Diabetes Technol Ther; 2021 Oct; 23(10):684-691. PubMed ID: 34042523
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system.
    Christoforidis A; Kavoura E; Nemtsa A; Pappa K; Dimitriadou M
    Diabetes Res Clin Pract; 2020 Aug; 166():108307. PubMed ID: 32650036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.